5ndw › Citations

Aminoglycoside interactions and impacts on the eukaryotic ribosome.

Fig. 1.
Fig. 2.
Fig. 3.
Prokhorova I, Altman RB, Djumagulov M, Shrestha JP, Urzhumtsev A, Ferguson A, Chang CT, Yusupov M, Blanchard SC, Yusupova G
OpenAccess logo Proc Natl Acad Sci U S A 114 E10899-E10908 (2017)
Related entries: 5ndg, 5ndj, 5ndk, 5ndv, 5obm

Cited: 92 times
EuropePMC logo PMID: 29208708

Abstract

Aminoglycosides are chemically diverse, broad-spectrum antibiotics that target functional centers within the bacterial ribosome to impact all four principle stages (initiation, elongation, termination, and recycling) of the translation mechanism. The propensity of aminoglycosides to induce miscoding errors that suppress the termination of protein synthesis supports their potential as therapeutic interventions in human diseases associated with premature termination codons (PTCs). However, the sites of interaction of aminoglycosides with the eukaryotic ribosome and their modes of action in eukaryotic translation remain largely unexplored. Here, we use the combination of X-ray crystallography and single-molecule FRET analysis to reveal the interactions of distinct classes of aminoglycosides with the 80S eukaryotic ribosome. Crystal structures of the 80S ribosome in complex with paromomycin, geneticin (G418), gentamicin, and TC007, solved at 3.3- to 3.7-Å resolution, reveal multiple aminoglycoside-binding sites within the large and small subunits, wherein the 6'-hydroxyl substituent in ring I serves as a key determinant of binding to the canonical eukaryotic ribosomal decoding center. Multivalent binding interactions with the human ribosome are also evidenced through their capacity to affect large-scale conformational dynamics within the pretranslocation complex that contribute to multiple aspects of the translation mechanism. The distinct impacts of the aminoglycosides examined suggest that their chemical composition and distinct modes of interaction with the ribosome influence PTC read-through efficiency. These findings provide structural and functional insights into aminoglycoside-induced impacts on the eukaryotic ribosome and implicate pleiotropic mechanisms of action beyond decoding.

Articles - 5ndw mentioned but not cited (1)

  1. Aminoglycoside interactions and impacts on the eukaryotic ribosome. Prokhorova I, Altman RB, Djumagulov M, Shrestha JP, Urzhumtsev A, Ferguson A, Chang CT, Yusupov M, Blanchard SC, Yusupova G. Proc Natl Acad Sci U S A 114 E10899-E10908 (2017)


Reviews citing this publication (19)

  1. The relationship between the structure and toxicity of aminoglycoside antibiotics. Jospe-Kaufman M, Siomin L, Fridman M. Bioorg Med Chem Lett 30 127218 (2020)
  2. A Quick Guide to Small-Molecule Inhibitors of Eukaryotic Protein Synthesis. Dmitriev SE, Vladimirov DO, Lashkevich KA. Biochemistry (Mosc) 85 1389-1421 (2020)
  3. Pharmacological approaches for targeting cystic fibrosis nonsense mutations. Sharma J, Keeling KM, Rowe SM. Eur J Med Chem 200 112436 (2020)
  4. Selective toxicity of antibacterial agents-still a valid concept or do we miss chances and ignore risks? Dalhoff A. Infection 49 29-56 (2021)
  5. Bicarbonate Transport in Cystic Fibrosis and Pancreatitis. Angyal D, Bijvelds MJC, Bruno MJ, Peppelenbosch MP, de Jonge HR. Cells 11 54 (2021)
  6. Molecular Insights into Determinants of Translational Readthrough and Implications for Nonsense Suppression Approaches. Lombardi S, Testa MF, Pinotti M, Branchini A. Int J Mol Sci 21 E9449 (2020)
  7. Identifying targets to prevent aminoglycoside ototoxicity. Kim J, Hemachandran S, Cheng AG, Ricci AJ. Mol Cell Neurosci 120 103722 (2022)
  8. Tools and basic procedures of gene manipulation in nematode-trapping fungi. Wang S, Liu X. Mycology 14 75-90 (2023)
  9. Cooperative Analysis of Structural Dynamics in RNA-Protein Complexes by Single-Molecule Förster Resonance Energy Transfer Spectroscopy. Meiser N, Fuks C, Hengesbach M. Molecules 25 E2057 (2020)
  10. Hiding in Plain Sight: Formation and Function of Stress Granules During Microbial Infection of Mammalian Cells. Tweedie A, Nissan T. Front Mol Biosci 8 647884 (2021)
  11. Emerging Personalized Opportunities for Enhancing Translational Readthrough in Rare Genetic Diseases and Beyond. Wagner RN, Wießner M, Friedrich A, Zandanell J, Breitenbach-Koller H, Bauer JW. Int J Mol Sci 24 6101 (2023)
  12. Inhibition of the Eukaryotic 80S Ribosome as a Potential Anticancer Therapy: A Structural Perspective. Pellegrino S, Terrosu S, Yusupova G, Yusupov M. Cancers (Basel) 13 4392 (2021)
  13. Nonsense Suppression Therapy: New Hypothesis for the Treatment of Inherited Bone Marrow Failure Syndromes. Bezzerri V, Api M, Allegri M, Fabrizzi B, Corey SJ, Cipolli M. Int J Mol Sci 21 E4672 (2020)
  14. Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development. Li S, Li J, Shi W, Nie Z, Zhang S, Ma F, Hu J, Chen J, Li P, Xie X. Biomolecules 13 988 (2023)
  15. Trends in Single-Molecule Total Internal Reflection Fluorescence Imaging and Their Biological Applications with Lab-on-a-Chip Technology. Colson L, Kwon Y, Nam S, Bhandari A, Maya NM, Lu Y, Cho Y. Sensors (Basel) 23 7691 (2023)
  16. Graph Theoretical Methods and Workflows for Searching and Annotation of RNA Tertiary Base Motifs and Substructures. Emrizal R, Hamdani HY, Firdaus-Raih M. Int J Mol Sci 22 8553 (2021)
  17. Nonsense Suppression Therapy: An Emerging Treatment for Hereditary Skin Diseases. Yu J, Tang B, He X, Zou P, Zeng Z, Xiao R. Acta Derm Venereol 102 adv00658 (2022)
  18. Readthrough Activators and Nonsense-Mediated mRNA Decay Inhibitor Molecules: Real Potential in Many Genetic Diseases Harboring Premature Termination Codons. Benslimane N, Loret C, Chazelas P, Favreau F, Faye PA, Lejeune F, Lia AS. Pharmaceuticals (Basel) 17 314 (2024)
  19. Recoding of Nonsense Mutation as a Pharmacological Strategy. Temaj G, Telkoparan-Akillilar P, Nuhii N, Chichiarelli S, Saha S, Saso L. Biomedicines 11 659 (2023)

Articles citing this publication (72)

  1. Small-Molecule Modulation of TDP-43 Recruitment to Stress Granules Prevents Persistent TDP-43 Accumulation in ALS/FTD. Fang MY, Markmiller S, Vu AQ, Javaherian A, Dowdle WE, Jolivet P, Bushway PJ, Castello NA, Baral A, Chan MY, Linsley JW, Linsley D, Mercola M, Finkbeiner S, Lecuyer E, Lewcock JW, Yeo GW. Neuron 103 802-819.e11 (2019)
  2. Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides. Wangen JR, Green R. Elife 9 e52611 (2020)
  3. A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion. Sharma J, Du M, Wong E, Mutyam V, Li Y, Chen J, Wangen J, Thrasher K, Fu L, Peng N, Tang L, Liu K, Mathew B, Bostwick RJ, Augelli-Szafran CE, Bihler H, Liang F, Mahiou J, Saltz J, Rab A, Hong J, Sorscher EJ, Mendenhall EM, Coppola CJ, Keeling KM, Green R, Mense M, Suto MJ, Rowe SM, Bedwell DM. Nat Commun 12 4358 (2021)
  4. Antibiotic Killing of Diversely Generated Populations of Nonreplicating Bacteria. McCall IC, Shah N, Govindan A, Baquero F, Levin BR. Antimicrob Agents Chemother 63 e02360-18 (2019)
  5. Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: The international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF). Konstan MW, VanDevanter DR, Rowe SM, Wilschanski M, Kerem E, Sermet-Gaudelus I, DiMango E, Melotti P, McIntosh J, De Boeck K, ACT CF Study Group. J Cyst Fibros 19 595-601 (2020)
  6. A structural inventory of native ribosomal ABCE1-43S pre-initiation complexes. Kratzat H, Mackens-Kiani T, Ameismeier M, Potocnjak M, Cheng J, Dacheux E, Namane A, Berninghausen O, Herzog F, Fromont-Racine M, Becker T, Beckmann R. EMBO J 40 e105179 (2021)
  7. Ataluren and aminoglycosides stimulate read-through of nonsense codons by orthogonal mechanisms. Ng MY, Li H, Ghelfi MD, Goldman YE, Cooperman BS. Proc Natl Acad Sci U S A 118 e2020599118 (2021)
  8. 2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations. Trzaska C, Amand S, Bailly C, Leroy C, Marchand V, Duvernois-Berthet E, Saliou JM, Benhabiles H, Werkmeister E, Chassat T, Guilbert R, Hannebique D, Mouray A, Copin MC, Moreau PA, Adriaenssens E, Kulozik A, Westhof E, Tulasne D, Motorin Y, Rebuffat S, Lejeune F. Nat Commun 11 1509 (2020)
  9. Deciphering the Nonsense Readthrough Mechanism of Action of Ataluren: An in Silico Compared Study. Tutone M, Pibiri I, Lentini L, Pace A, Almerico AM. ACS Med Chem Lett 10 522-527 (2019)
  10. The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential. Friesen WJ, Johnson B, Sierra J, Zhuo J, Vazirani P, Xue X, Tomizawa Y, Baiazitov R, Morrill C, Ren H, Babu S, Moon YC, Branstrom A, Mollin A, Hedrick J, Sheedy J, Elfring G, Weetall M, Colacino JM, Welch EM, Peltz SW. PLoS One 13 e0206158 (2018)
  11. Accuracy mechanism of eukaryotic ribosome translocation. Djumagulov M, Demeshkina N, Jenner L, Rozov A, Yusupov M, Yusupova G. Nature 600 543-546 (2021)
  12. Lipid composition and cell surface hydrophobicity of Candida albicans influence the efficacy of fluconazole-gentamicin treatment. Suchodolski J, Muraszko J, Korba A, Bernat P, Krasowska A. Yeast 37 117-129 (2020)
  13. Mechanisms that ensure speed and fidelity in eukaryotic translation termination. Lawson MR, Lessen LN, Wang J, Prabhakar A, Corsepius NC, Green R, Puglisi JD. Science 373 876-882 (2021)
  14. New in Vitro Assay Measuring Direct Interaction of Nonsense Suppressors with the Eukaryotic Protein Synthesis Machinery. Ng MY, Zhang H, Weil A, Singh V, Jamiolkowski R, Baradaran-Heravi A, Roberge M, Jacobson A, Friesen W, Welch E, Goldman YE, Cooperman BS. ACS Med Chem Lett 9 1285-1291 (2018)
  15. USP16 counteracts mono-ubiquitination of RPS27a and promotes maturation of the 40S ribosomal subunit. Montellese C, van den Heuvel J, Ashiono C, Dörner K, Melnik A, Jonas S, Zemp I, Picotti P, Gillet LC, Kutay U. Elife 9 e54435 (2020)
  16. Adaptation to genome decay in the structure of the smallest eukaryotic ribosome. Nicholson D, Salamina M, Panek J, Helena-Bueno K, Brown CR, Hirt RP, Ranson NA, Melnikov SV. Nat Commun 13 591 (2022)
  17. Real-time measurements of aminoglycoside effects on protein synthesis in live cells. Aguirre Rivera J, Larsson J, Volkov IL, Seefeldt AC, Sanyal S, Johansson M. Proc Natl Acad Sci U S A 118 e2013315118 (2021)
  18. An open interface in the pre-80S ribosome coordinated by ribosome assembly factors Tsr1 and Dim1 enables temporal regulation of Fap7. Rai J, Parker MD, Huang H, Choy S, Ghalei H, Johnson MC, Karbstein K, Stroupe ME. RNA 27 221-233 (2021)
  19. Drug-induced Stress Granule Formation Protects Sensory Hair Cells in Mouse Cochlear Explants During Ototoxicity. Gonçalves AC, Towers ER, Haq N, Porco JA, Pelletier J, Dawson SJ, Gale JE. Sci Rep 9 12501 (2019)
  20. A Flow Cytometry Method for Dissecting the Cell Differentiation Process of Entamoeba Encystation. Mi-Ichi F, Miyake Y, Tam VK, Yoshida H. Front Cell Infect Microbiol 8 250 (2018)
  21. New Negamycin-Based Potent Readthrough Derivative Effective against TGA-Type Nonsense Mutations. Hamada K, Omura N, Taguchi A, Baradaran-Heravi A, Kotake M, Arai M, Takayama K, Taniguchi A, Roberge M, Hayashi Y. ACS Med Chem Lett 10 1450-1456 (2019)
  22. Termi-Luc: a versatile assay to monitor full-protein release from ribosomes. Susorov D, Egri S, Korostelev AA. RNA 26 2044-2050 (2020)
  23. Translational readthrough of nonsense mutant TP53 by mRNA incorporation of 5-Fluorouridine. Palomar-Siles M, Heldin A, Zhang M, Strandgren C, Yurevych V, van Dinter JT, Engels SAG, Hofman DA, Öhlin S, Meineke B, Bykov VJN, van Heesch S, Wiman KG. Cell Death Dis 13 997 (2022)
  24. Frontotemporal dementia non-sense mutation of progranulin rescued by aminoglycosides. Kuang L, Hashimoto K, Huang EJ, Gentry MS, Zhu H. Hum Mol Genet 29 624-634 (2020)
  25. A dual role of the ribosome-bound chaperones RAC/Ssb in maintaining the fidelity of translation termination. Gribling-Burrer AS, Chiabudini M, Zhang Y, Qiu Z, Scazzari M, Wölfle T, Wohlwend D, Rospert S. Nucleic Acids Res 47 7018-7034 (2019)
  26. CTELS: A Cell-Free System for the Analysis of Translation Termination Rate. Lashkevich KA, Shlyk VI, Kushchenko AS, Gladyshev VN, Alkalaeva EZ, Dmitriev SE. Biomolecules 10 E911 (2020)
  27. Effects of amikacin, polymyxin-B, and sulbactam combination on the pharmacodynamic indices of mutant selection against multi-drug resistant Acinetobacter baumannii. Zhu S, Song C, Zhang J, Diao S, Heinrichs TM, Martins FS, Lv Z, Zhu Y, Yu M, Sy SKB. Front Microbiol 13 1013939 (2022)
  28. N1-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting. Mulroney TE, Pöyry T, Yam-Puc JC, Rust M, Harvey RF, Kalmar L, Horner E, Booth L, Ferreira AP, Stoneley M, Sawarkar R, Mentzer AJ, Lilley KS, Smales CM, von der Haar T, Turtle L, Dunachie S, Klenerman P, Thaventhiran JED, Willis AE. Nature 625 189-194 (2024)
  29. RNA Sequencing Reveals Specific TranscriptomicSignatures Distinguishing Effects of the [SWI⁺] Prion and SWI1 Deletion in Yeast Saccharomyces cerevisiae. Malovichko YV, Antonets KS, Maslova AR, Andreeva EA, Inge-Vechtomov SG, Nizhnikov AA. Genes (Basel) 10 E212 (2019)
  30. Mechanistic insights into translation inhibition by aminoglycoside antibiotic arbekacin. Parajuli NP, Mandava CS, Pavlov MY, Sanyal S. Nucleic Acids Res 49 6880-6892 (2021)
  31. Silver nanoparticles enhance the efficacy of aminoglycosides against antibiotic-resistant bacteria. Dove AS, Dzurny DI, Dees WR, Qin N, Nunez Rodriguez CC, Alt LA, Ellward GL, Best JA, Rudawski NG, Fujii K, Czyż DM. Front Microbiol 13 1064095 (2022)
  32. The catalytic activity of the translation termination factor methyltransferase Mtq2-Trm112 complex is required for large ribosomal subunit biogenesis. Lacoux C, Wacheul L, Saraf K, Pythoud N, Huvelle E, Figaro S, Graille M, Carapito C, Lafontaine DLJ, Heurgué-Hamard V. Nucleic Acids Res 48 12310-12325 (2020)
  33. 2-Guanidino-quinazoline promotes the readthrough of nonsense mutations underlying human genetic diseases. Bidou L, Bugaud O, Merer G, Coupet M, Hatin I, Chirkin E, Karri S, Demais S, François P, Cintrat JC, Namy O. Proc Natl Acad Sci U S A 119 e2122004119 (2022)
  34. An in vitro single-molecule assay for eukaryotic cap-dependent translation initiation kinetics. Wang H, Sun L, Gaba A, Qu X. Nucleic Acids Res 48 e6 (2020)
  35. Novel Translational Read-through-Inducing Drugs as a Therapeutic Option for Shwachman-Diamond Syndrome. Bezzerri V, Lentini L, Api M, Busilacchi EM, Cavalieri V, Pomilio A, Diomede F, Pegoraro A, Cesaro S, Poloni A, Pace A, Trubiani O, Lippi G, Pibiri I, Cipolli M. Biomedicines 10 886 (2022)
  36. Small molecule Y-320 stimulates ribosome biogenesis, protein synthesis, and aminoglycoside-induced premature termination codon readthrough. Hosseini-Farahabadi S, Baradaran-Heravi A, Zimmerman C, Choi K, Flibotte S, Roberge M. PLoS Biol 19 e3001221 (2021)
  37. The aminoglycoside G418 hinders de novo prion infection in cultured cells. Arshad H, Patel Z, Mehrabian M, Bourkas MEC, Al-Azzawi ZAM, Schmitt-Ulms G, Watts JC. J Biol Chem 297 101073 (2021)
  38. Cross organelle stress response disruption promotes gentamicin-induced proteotoxicity. Igwebuike C, Yaglom J, Huiting L, Feng H, Campbell JD, Wang Z, Havasi A, Pimentel D, Sherman MY, Borkan SC. Cell Death Dis 11 217 (2020)
  39. Cryo-EM structure of the ancient eukaryotic ribosome from the human parasite Giardia lamblia. Hiregange DG, Rivalta A, Bose T, Breiner-Goldstein E, Samiya S, Cimicata G, Kulakova L, Zimmerman E, Bashan A, Herzberg O, Yonath A. Nucleic Acids Res 50 1770-1782 (2022)
  40. Engineering and functional analysis of yeast with a monotypic 40S ribosome subunit. Hu X, Jiang S, Xu F, Zeng C, Wang X, Liu W, Cheng A, Ma C, Gao N, Zhao Y, Dai J, Zhao G. Proc Natl Acad Sci U S A 119 e2114445119 (2022)
  41. Exploring eukaryotic versus prokaryotic ribosomal RNA recognition with aminoglycoside derivatives. Sabbavarapu NM, Pieńko T, Zalman BH, Trylska J, Baasov T. Medchemcomm 9 503-508 (2018)
  42. Functional Studies on Novel RET Mutations and Their Implications for Genetic Counseling for Hirschsprung Disease. Wang H, Li Q, Zhang Z, Xiao P, Li L, Jiang Q. Front Genet 10 924 (2019)
  43. Geneticin shows selective antiviral activity against SARS-CoV-2 by interfering with programmed -1 ribosomal frameshifting. Varricchio C, Mathez G, Pillonel T, Bertelli C, Kaiser L, Tapparel C, Brancale A, Cagno V. Antiviral Res 208 105452 (2022)
  44. Identification of the genetic central dogma in osteogenic differentiation of MSCs by osteoinductive medium from transcriptional data sets. Jiang TM. Chronic Dis Transl Med 8 218-228 (2022)
  45. Protective Effect of Liposomal Epigallocatechin-Gallate in Experimental Gentamicin-Induced Hepatotoxicity. Bulboacă AE, Porfire AS, Rus V, Nicula CA, Bulboacă CA, Bolboacă SD. Antioxidants (Basel) 11 412 (2022)
  46. Topical antibiotics reduce CD11c+ cell numbers in the healthy murine cornea and modulate their response to contact lens wear. Datta A, Lee J, Truong T, Evans DJ, Fleiszig SMJ. Sci Rep 12 10655 (2022)
  47. Antimicrobial activity and molecular docking screening of bioactive components of Antirrhinum majus (snapdragon) aerial parts. Saqallah FG, Hamed WM, Talib WH, Dianita R, Wahab HA. Heliyon 8 e10391 (2022)
  48. Downstream Alternate Start Site Allows N-Terminal Nonsense Variants to Escape NMD and Results in Functional Recovery by Readthrough and Modulator Combination. Bowling A, Eastman A, Merlo C, Lin G, West N, Patel S, Cutting G, Sharma N. J Pers Med 12 1448 (2022)
  49. Paromomycin Reduces Vairimorpha (Nosema)ceranae Infection in Honey Bees but Perturbs Microbiome Levels and Midgut Cell Function. Cho RM, Kogan HV, Elikan AB, Snow JW. Microorganisms 10 1107 (2022)
  50. Potential for the Development of a New Generation of Aminoglycoside Antibiotics. Tevyashova AN, Shapovalova KS. Pharm Chem J 55 860-875 (2021)
  51. Smart-ORF: a single-molecule method for accessing ribosome dynamics in both upstream and main open reading frames. Gaba A, Wang H, Fortune T, Qu X. Nucleic Acids Res 49 e26 (2021)
  52. Structure-Based Design of a Eukaryote-Selective Antiprotozoal Fluorinated Aminoglycoside. Kanazawa H, Saavedra OM, Maianti JP, Young SA, Izquierdo L, Smith TK, Hanessian S, Kondo J. ChemMedChem 13 1541-1548 (2018)
  53. Use of a fluorescence assay to determine relative affinities of semisynthetic aminoglycosides to small RNAs representing bacterial and mitochondrial A sites. Waduge P, Sati GC, Crich D, Chow CS. Bioorg Med Chem 27 115121 (2019)
  54. Collateral Damage in the Human Gut Microbiome - Blastocystis Is Significantly Less Prevalent in an Antibiotic-Treated Adult Population Compared to Non-Antibiotic Treated Controls. Jeffery IB, Cotter PD, Scanlan PD. Front Cell Infect Microbiol 12 822475 (2022)
  55. Nonsense mutation suppression is enhanced by targeting different stages of the protein synthesis process. Wittenstein A, Caspi M, Rippin I, Elroy-Stein O, Eldar-Finkelman H, Thoms S, Rosin-Arbesfeld R. PLoS Biol 21 e3002355 (2023)
  56. Adaptive lifestyle of bacteria determines phage-bacteria interaction. Ulrich L, Giez C, Steiner LX, Hentschel U, Lachnit T. Front Microbiol 13 1056388 (2022)
  57. Antibiotics against Pseudomonas aeruginosa on Human Skin Cell Lines: Determination of the Highest Non-Cytotoxic Concentrations with Antibiofilm Capacity for Wound Healing Strategies. Quiñones-Vico MI, Fernández-González A, Ubago-Rodríguez A, Moll K, Norrby-Teglund A, Svensson M, Gutiérrez-Fernández J, Torres JM, Arias-Santiago S. Pharmaceutics 16 117 (2024)
  58. Attenuation of Rat Colon Carcinogenesis by Styela plicata Aqueous Extract. Modulation of NF-κB Pathway and Cytoplasmic Sod1 Gene Expression. Salim EI, El-Gamal MM, Mona MM, Abdelhady HA. Asian Pac J Cancer Prev 21 2739-2750 (2020)
  59. Balancing Nonsense Mutation Readthrough and Toxicity of Designer Aminoglycosides for Treatment of Genetic Diseases. Guchhait S, Khononov A, Pieńko T, Belakhov V, Baasov T. ACS Med Chem Lett 14 794-801 (2023)
  60. Concentration and time-dependent amyloidogenic characteristics of intrinsically disordered N-terminal region of Saccharomyces cerevisiae Stm1. Subbaiah S P V, Uttamrao PP, Das U, Sundaresan S, Rathinavelan T. Front Microbiol 14 1206945 (2023)
  61. Conjugation of Gentamicin to Polyamidoamine Dendrimers Improved Anti-bacterial Properties against Pseudomonas aeruginosa. Sheykhloo H, Milani M, Najafi F, Bani F, Zarebkohan A. Adv Pharm Bull 11 675-683 (2021)
  62. Design, Synthesis, and Characterization of a Novel 2'-5'-Linked Amikacin-Binding Aptamer: An Experimental and MD Simulation Study. Mathivanan J, Bai Z, Chen A, Sheng J. ACS Chem Biol 17 3478-3488 (2022)
  63. Development of Conformationally Restricted Negamycin Derivatives for Potent Readthrough Activity. Omura N, Taguchi A, Kuwahara T, Hamada K, Watanabe M, Nakakuki M, Konno S, Takayama K, Taniguchi A, Nomura T, Shuto S, Hayashi Y. ACS Med Chem Lett 14 1807-1814 (2023)
  64. En Route to Targeted Ribosome Editing to Replenish Skin Anchor Protein LAMB3 in Junctional Epidermolysis Bullosa. Wimmer B, Friedrich A, Poeltner K, Edobor G, Mosshammer C, Temaj G, Rathner A, Karl T, Krauss J, von Hagen J, Gerner C, Breitenbach M, Hintner H, Bauer JW, Breitenbach-Koller H. JID Innov 4 100240 (2024)
  65. Evaluation of Novel Enhancer Compounds in Gentamicin-Mediated Readthrough of Nonsense Mutations in Rett Syndrome. Wong KM, Wegener E, Baradaran-Heravi A, Huppke B, Gärtner J, Huppke P. Int J Mol Sci 24 11665 (2023)
  66. Geneticin reduces mRNA stability. Durmaz YT, Shatadal A, Friend K. PLoS One 17 e0272058 (2022)
  67. In Vitro Cross-Linking MS Reveals SMG1-UPF2-SMG7 Assembly as Molecular Partners within the NMD Surveillance. Padariya M, Vojtesek B, Hupp T, Kalathiya U. Int J Mol Sci 25 3182 (2024)
  68. In vitro models to detect in vivo bile acid changes induced by antibiotics. Zhang N, Wang J, Bakker W, Zheng W, Baccaro M, Murali A, van Ravenzwaay B, Rietjens IMCM. Arch Toxicol 96 3291-3303 (2022)
  69. Investigation of neomycin biodegradation conditions using ericoid mycorrhizal and white rot fungal species. Stenholm Å, Hedeland M, Pettersson CE. BMC Biotechnol 22 29 (2022)
  70. Pharmacological induction of translational readthrough of nonsense mutations in the retinoblastoma (RB1) gene. Palomar-Siles M, Yurevych V, Bykov VJN, Wiman KG. PLoS One 18 e0292468 (2023)
  71. Readthrough Approach Using NV Translational Readthrough-Inducing Drugs (TRIDs): A Study of the Possible Off-Target Effects on Natural Termination Codons (NTCs) on TP53 and Housekeeping Gene Expression. Perriera R, Vitale E, Pibiri I, Carollo PS, Ricci D, Corrao F, Fiduccia I, Melfi R, Zizzo MG, Tutone M, Pace A, Lentini L. Int J Mol Sci 24 15084 (2023)
  72. Systematic and quantitative analysis of stop codon readthrough in Rett syndrome nonsense mutations. Lebeda D, Fierenz A, Werfel L, Rosin-Arbesfeld R, Hofhuis J, Thoms S. J Mol Med (Berl) 102 641-653 (2024)


Quick links